-
Optimization of Selective Mu Opioid Receptor Antagonists for the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease
… Receptor Antagonists for the Treatment of Levodopa-Induced Dyskinesias in Parkinson's Disease Promising Outcomes of …
-
Ask the MD: Dyskinesia and Parkinson's Disease
September 14, 2017
… Dyskinesia is involuntary, irregular movement that can occur … or bothersome. Others actually prefer the extra movement of dyskinesia to being rigid or otherwise unable to move …
-
Effect of Novel Neuronal Nicotinic Receptor Compounds on Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease
… of L-dopa-induced abnormal involuntary movements (AIMs), or dyskinesias, stemmed from preclinical studies showing that …
-
Safety, Tolerability and Efficacy of ADX48621 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease
… of ADX48621 ( dipraglurant) in reducing levodopa-induced dyskinesia in patients with Parkinson’s disease (PD). … collect information on the effects of study medication on dyskinesias, PD symptoms and quality of life in between the …
-
Weighing Different Scales: Unified Dyskinesia Rating Scale Comes out on Top, Could Speed Development of New Dyskinesia Treatments
May 1, 2012
… scale for measuring patient response to therapies to treat dyskinesia, the debilitating, uncontrollable movements that … University Medical Center, demonstrated that the Unified Dyskinesia Rating Scale (UDysRS) most sensitively tracks …
-
Preclinical Evaluation of a 5-HT2A Antagonist for Treatment of L-DOPA-Induced Dyskinesias in Parkinson's Disease
… with the appearance of abnormal motor movements called dyskinesias. Medications effective in reducing the incidence …